Literature DB >> 3125391

Selection and procurement of combined heart and lung grafts for transplantation.

M Hakim1, T Higenbottam, D Bethune, R Cory-Pearce, T A English, J Kneeshaw, F C Wells, J Wallwork.   

Abstract

Between April 1984 and July 1986, 14 patients underwent heart-lung transplantation at Papworth Hospital, Cambridge, England. The donors for the first five operations were brought to our hospital and the organs removed in the operating theater adjacent to that in which the recipients were prepared. Subsequently, organs have been procured from distant centers. The total ischemic time ranged from 48 to 51 minutes (mean 49.6) for the near procurement group and from 70 to 186 minutes (mean 123.6) for the distant procurement group. Our method of preservation consists of cold cardioplegic arrest of the heart with St. Thomas' Hospital solution followed by a single cold (4 degrees C) pulmonary artery flush with a solution containing 500 ml donors blood, 700 ml Ringer's solution, 200 ml 20% salt-poor albumin, 100 ml 20% mannitol, 20 micrograms prostacyclin, and 10,000 units heparin. Function of the lungs after implantation was assessed by measuring the alveolar-arterial oxygen gradient. The median alveolar-arterial oxygen gradient measured shortly after discontinuation of bypass (point 1), just before extubation (point 2), and at 1 week (point 3) were 96.0, 62.3, and 18.8 mm Hg, respectively, for the near procurement group and 91.5, 60.0, and 11.3 mm Hg, respectively, for the distant procurement group. Comparison of the two groups at the three measurement points by the nonparametric Wilcoxon test showed no significant difference (p = 0.44, 0.52, and 0.11, respectively). The two groups showed significant decline of the alveolar arterial oxygen gradient differences over the first week (p = 0.004, nonparametric Friedman test). We conclude that our method of preservation provides a satisfactory function after implantation. The alveolar-arterial oxygen gradient differences were high immediately after implantation but decreased significantly afterward.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3125391

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  9 in total

1.  Intensive care management of children following heart and heart-lung transplantation.

Authors:  B Whitehead; I James; P Helms; J P Scott; R Smyth; T W Higenbottam; J McGoldrick; T A English; J Wallwork; M Elliott
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Organ donation. I--Management of the multiorgan donor.

Authors:  N J Odom
Journal:  BMJ       Date:  1990-06-16

Review 3.  Heart-lung transplantation for cystic fibrosis.

Authors:  T W Higenbottam; B Whitehead
Journal:  J R Soc Med       Date:  1991       Impact factor: 5.344

4.  Early experience of heart-lung transplantation.

Authors:  R L Smyth; T W Higenbottam; J P Scott; J P McGoldrick; B Whitehead; P Helms; M de Leval; J Wallwork
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

5.  [The concept of lung and heart-lung preservation within the scope of multiple organ procurement].

Authors:  H R Zerkowski; N Doetsch; A Hellinger; J C Reidemeister
Journal:  Langenbecks Arch Chir       Date:  1991

6.  Successful transplantation of marginally acceptable thoracic organs.

Authors:  I L Kron; C G Tribble; J A Kern; T M Daniel; C E Rose; J D Truwit; L H Blackbourne; J D Bergin
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

7.  Heart-lung transplantation for cystic fibrosis. 2: Outcome.

Authors:  B Whitehead; P Helms; M Goodwin; I Martin; J P Scott; R L Smyth; T W Higenbottam; J Wallwork; M Elliott; M de Leval
Journal:  Arch Dis Child       Date:  1991-09       Impact factor: 3.791

Review 8.  Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.

Authors:  S M Grant; K L Goa
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

9.  Lung protective ventilation based on donor size is associated with a lower risk of severe primary graft dysfunction after lung transplantation.

Authors:  Laneshia K Tague; Bahaa Bedair; Chad Witt; Derek E Byers; Rodrigo Vazquez-Guillamet; Hrishikesh Kulkarni; Jennifer Alexander-Brett; Ruben Nava; Varun Puri; Daniel Kreisel; Elbert P Trulock; Andrew Gelman; Ramsey R Hachem
Journal:  J Heart Lung Transplant       Date:  2021-07-10       Impact factor: 13.569

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.